Oliver Hoffmann

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

CD8 T-Cell Recognition of Multiple Epitopes within Specific Gag Regions Is Associated with Maintenance of a Low Steady-State Viremia in Human Immunodeficiency Virus Type 1-Seropositive Patients

Christof Geldmacher, Jeffrey R. Currier, Eva Herrmann et al. · Journal of Virology · 2006 · 159 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Alveolar Bone Preservation in Extraction Sockets Using Non‐Resorbable dPTFE Membranes: A Retrospective Non‐Randomized Study

Oliver Hoffmann, Barry K. Bartee, Christian Beaumont et al. · Journal of Periodontology · 2008 · 128 citations

Dentistry, Maxillofacial Surgery, Oral Surgery +17

Impact of the spheroid model complexity on drug response

Oliver Hoffmann, Christian Ilmberger, Stefanie Magosch et al. · Journal of Biotechnology · 2015 · 122 citations · Full text

Medicine, Oncology, Pharmacology +15

Prognostic relevance of activated Akt kinase in node-negative breast cancer: a clinicopathological study of 99 cases

Klaus J. Schmitz, Friedrich Otterbach, R. Callies et al. · Modern Pathology · 2003 · 88 citations

Medicine, Cancer Biology, Oncology +16